Advanced search
Publication Cover
Renal Failure Volume 37, 2015 - Issue 9
Submit an article Journal homepage
1,255
Views
9
CrossRef citations to date
0
Altmetric
Brief Report

The effectiveness and safety of rituximab as induction therapy in ABO-compatible non-sensitized renal transplantation: a systematic review and meta-analysis of randomized controlled trials

Wisit CheungpasitpornDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA, Correspondence[email protected]
,
Charat ThongprayoonDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA,
,
Peter J. EdmondsSUNY Upstate Medical University, Syracuse, NY, USA,
,
Jackrapong BruminhentDepartment of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand, and
&
Kawin TangdhanakanondDepartment of Renal Medicine, Alexandra Hospital, Singapore, Singapore
Pages 1522-1526 | Received 14 Jun 2015, Accepted 24 Jul 2015, Published online: 31 Aug 2015

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.